NO164275C - Fremgangsmaate for fremstilling av et fosfolipid-preparat. - Google Patents

Fremgangsmaate for fremstilling av et fosfolipid-preparat.

Info

Publication number
NO164275C
NO164275C NO844585A NO844585A NO164275C NO 164275 C NO164275 C NO 164275C NO 844585 A NO844585 A NO 844585A NO 844585 A NO844585 A NO 844585A NO 164275 C NO164275 C NO 164275C
Authority
NO
Norway
Prior art keywords
preparing
procedure
phosphatidylethanolamine
weight
phospholipid preparation
Prior art date
Application number
NO844585A
Other languages
English (en)
Other versions
NO844585L (no
NO164275B (no
Inventor
Francesco Della Valle
Aurelio Romeo
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of NO844585L publication Critical patent/NO844585L/no
Publication of NO164275B publication Critical patent/NO164275B/no
Publication of NO164275C publication Critical patent/NO164275C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J7/00—Phosphatide compositions for foodstuffs, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Dispersion Chemistry (AREA)
  • Neurology (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Epoxy Resins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Heat Treatment Of Steel (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO844585A 1983-11-17 1984-11-16 Fremgangsmaate for fremstilling av et fosfolipid-preparat. NO164275C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT49355/83A IT1212900B (it) 1983-11-17 1983-11-17 Uso terapeutico della fosfatidilserina in malattie del sistema nervoso centrale senza effetti sulla coagulazione sanguigna

Publications (3)

Publication Number Publication Date
NO844585L NO844585L (no) 1985-05-20
NO164275B NO164275B (no) 1990-06-11
NO164275C true NO164275C (no) 1990-09-19

Family

ID=11270453

Family Applications (1)

Application Number Title Priority Date Filing Date
NO844585A NO164275C (no) 1983-11-17 1984-11-16 Fremgangsmaate for fremstilling av et fosfolipid-preparat.

Country Status (25)

Country Link
US (1) US4595680A (no)
EP (1) EP0148045B1 (no)
JP (1) JPH0676334B2 (no)
KR (1) KR870001330B1 (no)
AT (1) ATE35415T1 (no)
AU (1) AU572228B2 (no)
BE (1) BE901074A (no)
CH (1) CH661734A5 (no)
DE (1) DE3472406D1 (no)
DK (1) DK168271B1 (no)
ES (1) ES8608528A1 (no)
FI (1) FI79946C (no)
FR (1) FR2555050B1 (no)
GR (1) GR80951B (no)
HU (1) HU193302B (no)
IE (1) IE58130B1 (no)
IL (1) IL73420A (no)
IN (1) IN162717B (no)
IT (1) IT1212900B (no)
LU (1) LU85639A1 (no)
MX (1) MX160792A (no)
NO (1) NO164275C (no)
NZ (1) NZ210091A (no)
PT (1) PT79510B (no)
ZA (1) ZA848776B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471776A1 (fr) * 1979-12-21 1981-06-26 Oreal Nouveaux agents cosmetiques a base de polymeres cationiques, compositions cosmetiques les contenant, et leur application
IT1213034B (it) * 1986-02-12 1989-12-07 Istituto Chemioterapico Di Lod Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale.
US5314695A (en) * 1990-11-13 1994-05-24 Corvas International, Inc. Tissue factor based prothrombin time reagent
FR2673512B1 (fr) * 1991-03-05 1993-08-20 Inst Rech Biolog Sa Nouvelles compositions dietetiques a base de lipides complexes phosphores et leur utilisation dans les troubles du sommeil.
IT1247165B (it) * 1991-03-15 1994-12-12 Fidia Spa Uso terapeutico della fosfatidilserina e derivati in patologie degenerative anche associate a disfunsioni immunitarie.
IT1248012B (it) * 1991-06-07 1995-01-05 Mediolanum Farmaceutici Spa Impiego del fosfatidilinositolo per la terapia dei disturbi della depressione.
IT1260149B (it) * 1992-04-17 1996-03-28 Fidia Spa Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali
GB9621293D0 (en) * 1996-10-11 1996-11-27 Scotia Holdings Plc Formulations containing unsaturated fatty acids
CA2393595A1 (en) * 1999-12-10 2001-06-14 Gigi Chiu Lipid carrier compositions with protected surface reactive functions
US7226916B1 (en) * 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
CA2319928A1 (en) 2000-09-18 2002-03-18 Vasogen Ireland Limited Apoptosis-mimicking synthetic entities and use thereof in medical treatments
TWI281407B (en) * 2000-09-18 2007-05-21 Vasogen Ireland Ltd Apoptosis-mimicking synthetic entities and use thereof in medical treatment
US6676963B1 (en) * 2000-10-27 2004-01-13 Barnes-Jewish Hospital Ligand-targeted emulsions carrying bioactive agents
WO2003013549A2 (de) * 2001-08-09 2003-02-20 Degussa Food Ingredients Gmbh Formulierung enthaltend (lyso-) phosphatidylserin zur vorbeugung und behandlung von stresszuständen bei warmblütern
EP1503742A2 (de) * 2002-04-19 2005-02-09 Bioghurt Biogarde GmbH & Co. KG. Matrix mit einer bioaktiven phospholipid-haltigen komponente
US6878532B1 (en) 2003-04-28 2005-04-12 Sioux Biochemical, Inc. Method of producing phosphatidylserine
CN1308334C (zh) * 2004-06-01 2007-04-04 山东师范大学 一种从动物脑提取磷脂酰丝氨酸的方法
IL182372A0 (en) * 2007-04-01 2008-01-20 Enzymotec Ltd Compositions containing phosphatidylserine in treating diabetes-associated conditions
ITMI20121784A1 (it) * 2012-10-22 2014-04-23 Velleja Res Srl Composizioni galattogeniche a base di fosfatidilserina
WO2015069870A1 (en) * 2013-11-07 2015-05-14 The University Of North Carolina At Chapel Hill Particles containing phospholipids or bioactive fatty acid
IT202100032252A1 (it) * 2021-12-22 2023-06-22 Fidia Farm Spa Processo di estrazione e purificazione industriale di fosfolipidi

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3156616A (en) * 1958-11-14 1964-11-10 Canada Majesty In Right Of Composition and method for correcting foods and blood conditions having clot promoting characteristics
US3436413A (en) * 1965-12-21 1969-04-01 Canada Packers Ltd Process for the isolation of phosphatidyl serine
FR5060M (no) * 1965-12-22 1967-05-08
US4078052A (en) * 1976-06-30 1978-03-07 The United States Of America As Represented By The Secretary Of Health, Education And Welfare Large unilamellar vesicles (LUV) and method of preparing same
JPS55115824A (en) * 1979-02-28 1980-09-06 Nippon Shoji Kk Remedy for clouding of consciousness and sensomobile disorder

Also Published As

Publication number Publication date
IN162717B (no) 1988-07-02
DK168271B1 (da) 1994-03-07
NO844585L (no) 1985-05-20
ES537575A0 (es) 1986-07-16
AU572228B2 (en) 1988-05-05
NZ210091A (en) 1988-06-30
KR850003504A (ko) 1985-06-20
IT1212900B (it) 1989-11-30
FI844468A0 (fi) 1984-11-14
FI79946C (fi) 1990-04-10
JPH0676334B2 (ja) 1994-09-28
DE3472406D1 (en) 1988-08-04
IL73420A (en) 1988-06-30
ATE35415T1 (de) 1988-07-15
HU193302B (en) 1987-09-28
FR2555050B1 (fr) 1986-12-26
FI844468L (fi) 1985-05-18
MX160792A (es) 1990-05-17
IE58130B1 (en) 1993-07-14
IE842785L (en) 1985-05-17
PT79510B (en) 1986-09-08
LU85639A1 (fr) 1985-06-04
IT8349355A0 (it) 1983-11-17
BE901074A (nl) 1985-05-17
KR870001330B1 (ko) 1987-07-18
DK524884D0 (da) 1984-11-02
IL73420A0 (en) 1985-02-28
HUT35957A (en) 1985-08-28
PT79510A (en) 1984-12-01
JPS60132921A (ja) 1985-07-16
ES8608528A1 (es) 1986-07-16
EP0148045B1 (en) 1988-06-29
NO164275B (no) 1990-06-11
GR80951B (en) 1984-12-18
ZA848776B (en) 1986-06-25
FR2555050A1 (fr) 1985-05-24
EP0148045A1 (en) 1985-07-10
FI79946B (fi) 1989-12-29
US4595680A (en) 1986-06-17
DK524884A (da) 1985-05-18
CH661734A5 (fr) 1987-08-14
AU3563084A (en) 1985-05-30

Similar Documents

Publication Publication Date Title
NO164275C (no) Fremgangsmaate for fremstilling av et fosfolipid-preparat.
ES542321A0 (es) Un procedimiento para la preparacion de derivados de la 2 pirimidinil-1-piperazina
BR8305616A (pt) Composicao sinergica retardadora de incendio, processo para sua preparacao e processo para a preparacao de um poliuretano ou poliisocianurato
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
ATE53038T1 (de) Inositoltriphosphat, verfahren zu seiner herstellung und dieses enthaltende zubereitung.
ES8600060A1 (es) Procedimiento para preparar un medicamento envasado que contiene como sustancia activa un antagonista del calcio tal como nifedipina, verapamil diltiazem y otros.
FR2378521A1 (fr) Derives du carbostyrile, utiles notamment comme stimulants des centres b- adrenorecepteurs, et leur procede de preparation
GB1525885A (en) Vincamine salt of pyridoxal phosphate
PT79648B (de) Verfahren zur herstellung von pharmazeutischen zubereitungen mit speziellen 1,2-diacyl-glycero-3-phosphocholinen zur behandlung von erkrankungen im magen-darm-bereich
ATE59295T1 (de) Prazosin-pirbuterol-mischung zur bronchendilatation.
ES8705439A1 (es) Procedimiento para preparar derivados de pirazol-(1,5-a)piridina
ES8700257A1 (es) Procedimiento para preparar derivados de pirazol(1,5-a) pi- ridina
ES8200871A1 (es) Procedimiento para la obtencion de derivados de 2-amino-3,4-dihidropiridina
IT1197637B (it) Procedimento per la preparazione di miscele stabili carbone-acqua
ES549982A0 (es) Procedimiento para preparar 6-sustituido-5-feniltetrazol (1,5-a)-(1,2,4)triazol-(1,5-c)pirimidinas